Mizuho downgraded Hologic (HOLX) to Neutral from Outperform with a $78 price target after the company agreed to be acquired by funds managed by Blackstone (BX) and TPG (TPG) in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3B.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Wall Street Hits Pause on Hologic Stock (HOLX) after $18B Buyout Offer
- Hologic downgraded to Equal Weight from Overweight at Stephens
- Hologic downgraded to Neutral from Overweight at JPMorgan
- Hologic downgraded to Market Perform from Outperform at Raymond James